| Issue | Title | |
| Vol 2011, No 6 (2011) | Johnson & Johnson | Abstract |
| Nigel Borshell | ||
| Vol 2012, No 1 (2012) | Johnson & Johnson | Abstract |
| Nigel Borshell | ||
| Vol 2012, No 3 (2012) | Johnson & Johnson | Abstract |
| Nigel Borshell, Taskin Ahmed | ||
| Vol 2012, No 4 (2012) | Johnson & Johnson | Abstract |
| Heather Cartwright, Taskin Ahmed | ||
| Vol 2013, No 1 (2013) | Johnson & Johnson | Abstract |
| Heather Cartwright, Taskin Ahmed | ||
| Vol 2012, No 2 (2012) | Johnson and Johnson | Abstract |
| Nigel Borshell | ||
| Vol 2011, No 1 (2011) | Merck | Abstract |
| Nigel Borshell | ||
| Vol 2011, No 2 (2011) | Merck | Abstract |
| Nigel Borshell | ||
| Vol 2011, No 3 (2011) | Merck | Abstract |
| Nigel Borshell | ||
| Vol 2011, No 4 (2011) | Merck | Abstract |
| Nigel Borshell | ||
| Vol 2011, No 5 (2011) | Merck | Abstract |
| Nigel Borshell | ||
| Vol 2011, No 6 (2011) | Merck | Abstract |
| Nigel Borshell | ||
| Vol 2012, No 1 (2012) | Merck | Abstract |
| Nigel Borshell | ||
| Vol 2012, No 2 (2012) | Merck | Abstract |
| Nigel Borshell | ||
| Vol 2013, No 1 (2013) | Merck | Abstract |
| Heather Cartwright, Taskin Ahmed | ||
| Vol 2012, No 3 (2012) | Merck & Co | Abstract |
| Nigel Borshell, Taskin Ahmed | ||
| Vol 2012, No 4 (2012) | Merck & Co | Abstract |
| Heather Cartwright, Taskin Ahmed | ||
| Vol 2011, No 2 (2011) | Monthly Review August 2011 | Abstract |
| Heather Cartwright | ||
| Vol 2011, No 3 (2011) | Monthly Review September 2011 | Abstract |
| Heather Cartwright | ||
| Vol 2011, No 1 (2011) | Novartis | Abstract |
| Nigel Borshell | ||
| Vol 2011, No 2 (2011) | Novartis | Abstract |
| Nigel Borshell | ||
| Vol 2011, No 3 (2011) | Novartis | Abstract |
| Nigel Borshell | ||
| Vol 2011, No 4 (2011) | Novartis | Abstract |
| Nigel Borshell | ||
| Vol 2011, No 5 (2011) | Novartis | Abstract |
| Nigel Borshell | ||
| Vol 2011, No 6 (2011) | Novartis | Abstract |
| Nigel Borshell | ||
| 76 - 100 of 143 Items | << < 1 2 3 4 5 6 > >> | |